Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 60 stories
14 October 2025 – 1 mins read
Testing Rating & Ranking
In 2023, we entered the next phase of our journey of growth and innovation, reinforcing our position as a leading mid-sized biopharmaceutical company. With a sharp focus on our three therapy areas of Oncology, Rare Diseases, and Neuroscience, we achieved total sales of €3,128 m.
02 July 2025 – 1 mins read
Test story
a test story to check media. website uses cookies to improve user experience. You may review Cookies Settings by following the link, or Reject All or Accept All Cookies from this page by using the buttons. You are directing us…
27 May 2025 – 1 mins read
Test story
a test story to check media. website uses cookies to improve user experience. You may review Cookies Settings by following the link, or Reject All or Accept All Cookies from this page by using the buttons. You are directing us…
05 May 2025 – 1 mins read
Our 2023 Integrated Annual Report is live!
In 2023, we entered the next phase of our journey of growth and innovation, reinforcing our position as a leading mid-sized biopharmaceutical company. With a sharp focus on our three therapy areas of Oncology, Rare Diseases, and Neuroscience, we achieved total sales of €3,128 m.
06 March 2025 – 1 mins read
Elastic test post
test
